A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
Clinical trial NCT02069119 · COMPLETED
Trial details
- NCT number
- NCT02069119
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-08-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.